The global Drug Delivery Technology Market is expected to be valued at US$ 39,330 Million in 2022. Increasing adoption of advanced technology for effectively delivering the drug to the target site is expected to drive overall market growth. The overall demand for drug delivery technology is projected to grow at a CAGR of 13.3% between 2022 and 2032, totalling around 137,615.91 Million by 2032. FMI, …
Category Archives: Healthcare Trends
Dental Ceramics Market to Exhibit US$ 572 million Revenue by the year 2032 at a CAGR of 4.9%
The global Dental Ceramics Market is expected to showcase a moderate pace of around 4.9% CAGR during the forecast period from 2022 to 2032. The global market is currently valued at US$ 339 million in 2022 and is anticipated to reach a high of around US$ 572 million by the year 2032. The growth in …
Cloud Based Drug Discovery Platform Market | Accenture PLC, BioXcel Corporation, Cloud Pharmaceuticals, Inc., WuXi AppTec | By 2032
The Cloud Based Drug Discovery Platform Market is anticipated to grow at a rapid CAGR of 12.6% over the course of the forecast period. In 2022, the market will be worth US$ 2,424.33 Million. By the year 2032, it is predicted that the market for cloud-based drug discovery platforms would reach a high of US$ …
Cosmetology Market | GC Aesthetics, Mentor Worldwide LLC, Sientra Inc., Zimmer Holdings Inc. | By 2032
The estimated value of the worldwide Cosmetology Market in 2022 is US$108.3 billion. By 2032, the market is expected to have grown by 10.9% CAGR from 2022 to 2032, approaching US$ 336.53 billion. Cosmetology is the study of beauty, treatments and its applications. There are various branches of specialty in the cosmetology market, i.e. hairstyling, skin …
Persistent Epithelial Defect Management is projected a market size of US$ 44.49 Billion, with a steady 18% CAGR from 2023 to 203
According to Future Market Insights, the market for Persistent Epithelial Defect Management is projected to rise at a steady growth valued at US$ 8.5 billion with 18% CAGR until 2033, being valued at US$ 44.49 billion. The Persistent Epithelial Defect (PED) market report provides current treatment practices, emerging drugs, market share of individual therapies, and …
Triptorelin Market is anticipated to produce US$ 1556.41 million, with the rise at a robust CAGR of 5% from 2023 to 2033
The Triptorelin Market is expected to be worth around US$ 955.50 million in 2023. Industry is predicted to expand at a 5% CAGR from 2023 to 2033, powered by the rising prevalence of endometriosis among females worldwide. By 2033, the triptorelin market is expected to generate US$ 1556.41 million. Dynamics of the Market Due to increased rates …
Drug Discovery Outsourcing Market expected to have a CAGR of 7.2% and anticipated to hold a share of US$ 7.52 Billion by 2033.
The Drug Discovery Outsourcing Market demand is expected to grow at a stable CAGR of 7.2% between 2023 and 2033. The market is expected to surpass a market share of US$ 7.52 billion by 2033, from a value of US$ 3.75 billion in 2023. The pharmaceutical industry’s expansion, as well as the increased penetration of …
Small-scale Bioreactors Market is projected to record a CAGR of 14.8%. to grow US$ 7.71 Billion by 2033
The global small-scale bioreactors market is predicted to register a CAGR of 14.8% over the forecast period, as per FMI’s analysis. The industry’s size is anticipated to increase from US$ 1.94 billion in 2023 to US$ 7.71 billion by 2033 end. New therapies are expected to be increasingly developed in the coming years due to the increased likelihood demand for dedicated manufacturing processes. …
Vascular Dementia Treatment Market is expected to reach US$ 8.99 Billion by 2033 and expand at a CAGR of 4.77% from 2023 to 2033
According to a recent report published by Future Market Insights, The projected growth for Vascular Dementia Treatment Market indicates an increase in market value to US$ 5.64 billion in FY 2023, reflecting a year-on-year rise of over 5%. Moreover, the market is expected to grow at a compound annual growth rate (CAGR) of 4.77% during the …
Blood Cancer Treatment Demand (Leukemia, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Multiple Myeloma) Market is forecast to grow at a CAGR of 10.2% from 2022 to 2032
Global Blood Cancer Treatment Demand (Leukemia, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Multiple Myeloma) Market is expected to be valued at US$ 5,489.3 million in 2022, rising at a 10.2% CAGR to US$ 12,943.6 million from 2022 to 2032. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an …